Homecare Dialysis Solutions
Global Trends Don’t Reflect the CKD Reality
The age for Stage 5 CKD is falling , as the overall profile of Diabetes and Hypertension suffers falls.
China will change the CKD map
Estimated that China = 4x US CKD suffers120 million in China with CKD1.5 million on dialysisForecast to double to 3 million by 2022
Cost differential in China between Clinic is smaller due to lower Medical costs, but expected to raise to a more western model of care
Dialysis treatment is Clinic Focused and Expensive
• Ireland = 166,603 dialysis sessions per annum • Cost of €73,139 million • (2- 3 % of the total Healthcare budget)
• Patients require 3 sessions per week = 156 p.a. • Cost average, €439.00 per session
• Cost In Clinic Haemodialysis €41,250.00 p.p.p.a. • Cost Average Haemodialysis €68,484.00 p.p.p.a. (clinic/
meds / doctors & support / transport )
• COST OF Home Dialysis €22-25,000 per person p.a.
Total No. of Renal Treatment Patients - Ireland
Transplant 54.5%
Haemodialysis, 39.3%
Peritoneal 6.2%
3960 Patients
Home €25K p.a. Vs Clinic/Hospital 75K p.a.
1. Begin day
4. Dialysis treatment and acquiring intra-dialysis data
3. Take responsibility for patients and pre dialysis data (PPC)
6. Post-dialysis data
7. Release patients
8. Find the back hometransport
Clinic Dialysis = 6-9 Intensive Hours / Day
2. Organize the transport to clinic
Home Dialysis : Solving the platform puzzle !
The Health Provider Reduce costs & better
dialysis results
The Patient & Family
To enjoy a Longer and better quality of life via HHD you need first to
convince them to leave , manage transition & maintain wellbeing.
The Manufacturer Better, more
compelling product & develop client loyalty.
Nephrologists & Hospitals
Better & more effective patient & data management
Researchers Stream of highly
precise and valuable data
TelecomsConnected data
Call Centre Service
We Know the Benefits Of Home Dialysis
• Lower Cost• Lower Stress• Reduced Meds• Flexible Plan• Personalised Plan• Health Benefits (Tax
& Earnings)• Work Benefits (Tax
& Earnings)• Holiday Benefits
The Challenge is Getting them There
• To meet chronic capacity & cost constraints, governments in the OECD need to shift at least 20% of all clinic based dialysis patients to their homes over the next 10 years. Getting & keeping them there is the challenge
• Some Home dialysis is happening – but very dependent on Clinician skills and resources. • Most Healthcare provider – reach a plateau get only the most motivated patients into the
home• An objective, consistent, professional & automated system is required to empower and
encourage more patients into the home regardless of what machine they use
The aim of this support tool is to first train patients in home dialysis through our unique applied solution
Once they are in their home support them in the management of their home dialysis.
We are seeking to collaborative and work directly with organisations and partnering institutions (Tyndall) to scale our solution to transform chronic healthcare management from
the clinic to the home.
Support Training & Increase Transfer To home
Education TrainingMonitoring
& Risk Evaluator
Patient Assessment &
rating
P1 -Home Therapy Trainer – Digital Process
• Increase Home Transfer rate - Pre-dialysis training• Ireland – min 20% regardless of local staffing resources
• HDSolutions market research of patients as id 5 categories we are confident of at least 20% take-up of home dialysis with proper training and support)
• Reduce HSE overhead for ESKD management ( est.50%-66%)
• Measure - Attitudes, Emotions & Difficulties• Implement -Staff & Patients & other modifications
• Test - Effectiveness/usability of the HDSolutions Digital P1 training
• Prototype solution on the 3 categories of test subjects; • A - Nurse, B - Patient & C - Caregiver.
P2 – Home Therapy Manager
Empowered Patient in
their home
(KT/V)2
Phosphates
DIET PROGRAM STRESS DIALYSIS INFORMATION DIALYSIS TIME
• Once in the Home give better analysis into the patients hands
Empowering people to manage their condition better • External monitoring – overcoming distance anxiety
System Architecture
• It delivers at level of cost to the Health provider substantially lower than the present alternative
• Increases efficient and deal with the emerging capacity crunch in the management of this chronic condition
• It is being developed manufactured and will be exported from Ireland.
P1 Trainer - Summary• Machine Self Use Training • Nurse Monitoring of Patient Home Training- Risk Evaluation• Patient Monitoring of their Home Training- Risk Evaluation• Nurse Monitoring of Home Help Training• Home Yes /No check list evaluator. • Home System management (water filtering machine, secured
power supply)
HSE Engagement-To-Date:• Agreement Clinical Director – National Renal Office Test-Trial
• University Hospital Cork• Waterford University Hospital
• Costing and support for Testing Trial – €155,000-175,000 – €25,000 commitment from HSE budgets – Richard Corbridge
ForecastPhases Phase 1
14 monthsPhase 2
10 monthsPhase 3
12 monthsPhase 4
12 monthsPhase 5
12 monthsInvestment
Requirement€610,000* €900,000* €900,000 €600,000 €600,000
Scope MVP & Trial*Not including €150,000 seed funding & feasibility analysis
Rollout HSE/NHS- Ireland- UK
Rollout EU- Germany- Italy- Portugal- Switzerland
Rollout US & Asia- USA- Japan- Taiwan- Hong
Kong- Shanghai
Rollout Middle East- UAE- Qatar- Saudi
Arabia- Bahrain
Clients (Compounded)
10 74 (+64) 215 (+141) 503 (+288) 809 (+396)
Deliverables Product Dev.Testing & TrialIP Buyout/Reg.Medical Contacts Centre (MCC)
Sales & Marketing rolloutExpansion InfrastructureExpand MCC
Expansion into EUScale up ESKD management
Expansion into US and Japan, Tiawan, HK Scale up ESKD iv management
Expansion into UAE. Scale up ESKD iv management
Software Roadmap
Ver1.0 Ver1.1 Ver1.2 Ver2.0 Ver2.1
Revenue €0 €1,491,100 €3,283,450 €6,670,435 €9,929,701Profits -€588,704 €60,092 €594,137 €2,625,367 €4,521,338
By the end of phase 2 - €1,510,000 has been invested and the business is cash positive. Subsequent investment , are not reflected in the forecast,Option at the end of Phase 21. engage with a strategic industry partner e.g. Baxter Health care, exit and ‘sell’ the project- deliver a modest return between €9 &10 million. (Gross
Earnings X 6)2. undertake a third round of build & evolved product in the EU & US market. -Phase 3-5.
Application Sales Earning breakdownP1 Trainer Software •(Once Off) Main Hospital Unit License €25.000 X 1 (Basic Package)*
€25,000.00•Per Patient Annual License €1.100 X 30 =
€33,000.00•Yearly SW upgrade €2.500 =
€2,500.00•SW trainer consultant € 850 per day X 30 Days PA =
€25,500.00•*(Advanced Package add 50%)
P2 Home Manager Software •Per Patient Annual License €1.100 X 30 =
€33,000.00•SW trainer consultant € 850 per day X 30 Days PA =
€25,500.00•Per Patient Annual License € 400.00 X 30 =
€12,000.00
Total Year 1 BM Hospital €168,000.00•Recurring License Revenue PA Per 30 HHD persons
€ 66,000.00•Recurring Consultants Revenue PA Per 30 HHD persons
€ 30,000.00(Based upon 1 day per patient)
Total Recurring € 96,000.00•Set Up /One Off. Earnings Per Patient
€5,600.00•Recurring Earnings Per HHD Patient PA
€3,200.00
Developing Strategy
Irish National Health Irish Medical Trail Partners
Developing StrategyMario NegriItalian Medical Trail Partner
Hospital NiguardaItalian Medical Trail partner
Dialysis Hardware Partner
PolitechnicoMilano
Trial Partners
Software Platform Partner
HMI Partner
Thank You.